(Q44101740)

29 November 2017

Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients (English)

1 reference

29 November 2017

Gaetano Ciancio

1

1 reference

29 November 2017

G W Burke

2

1 reference

29 November 2017

K Suzart

3

1 reference

29 November 2017

A Mattiazzi

4

1 reference

29 November 2017

A Rosen

5

1 reference

29 November 2017

G Zilleruello

6

1 reference

29 November 2017

C Abitbol

7

1 reference

29 November 2017

B Montane

8

1 reference

29 November 2017

J Miller

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Transplantation Proceedings

29 November 2017

1 reference

29 November 2017

34

1 reference

29 November 2017

5

1 reference

29 November 2017

1944-1945

1 reference

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Pediatric renal transplantation under tacrolimus-based immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

New immunosuppressive agents in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Single-center experience with mycophenolate mofetil in pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Tacrolimus-based immunosuppression in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903131-7

7 January 2021

10.1016/S0041-1345(02)03131-7

Identifiers

DOI

1 reference

29 November 2017

1 reference